Alphatec Strengthens Scientific Advisory Board with the Appointment of J. Patrick Johnson, M.D., M.S.
08 Februar 2007 - 5:15PM
PR Newswire (US)
CARLSBAD, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Alphatec
Holdings, Inc. (NASDAQ:ATEC), a medical device company that
provides customized products and a broad suite of solutions for
spinal surgery, announced today that it has named J. Patrick
Johnson, M.D., M.S., to its Scientific Advisory Board. Dr. Johnson
is Director of the Cedars-Sinai Institute for Spinal Disorders in
Los Angeles and Co-Director of Cedars-Sinai's Hyperhidrosis Center.
Dr. Johnson also serves as Consultant Neurosurgeon at Fort Harrison
VA Medical center in Helena, Montana; and is an Attending
Neurosurgeon at Cedars-Sinai Medical Center, Santa Monica-UCLA
Medical Center, St. John's Hospital in Santa Monica, West Los
Angeles VA Medical Center, and Harbor/UCLA Medical Center in
Torrance. "Through his commitment to innovative treatments, Dr.
Johnson has repeatedly proven himself to be one of this country's
premier thought leaders in the realm of neuro/spinal surgery, and
we are extremely proud that he has agreed to serve on our
Scientific Advisory Board," said John Foster, Chairman, President
and Chief Executive Officer of Alphatec. "Dr. Johnson's
contributions to the neurosurgical community have been invaluable
and his experience and knowledge will be powerful assets to the
development of our products, further underscoring Alphatec's growth
strategy and commitment to surgeon-driven product innovation." Dr.
Johnson's current areas of research include the development of
computerized image guided spinal stereotaxic technology; minimally
invasive and endoscopic spinal surgery; bone morphogenetic protein
in spinal fusion; outpatient lumbar microdiscectomy; vertebral body
replacement; and artificial disc replacement for the cervical and
lumbar spine. Dr. Johnson has led and participated in numerous
clinical studies involving the treatment of spinal disorders and
has authored a number of papers published in clinical journals. He
is a member of an array of professional organizations, including
the Congress of Neurological Surgeons, the American Association of
Neurological Surgeons, the American College of Surgeons, the North
American Spine Society and the California Association of
Neurological Surgeons, among others. Dr. Johnson received a
Bachelors of Science degree in Chemistry from The Citadel in
Charleston, South Carolina, and then attended Oregon Health
Sciences University where he received both a Masters of Science
degree in anatomy and neuroendocrinology and his medical degree. He
completed his surgical internship and neurosurgery residency at The
University of California, Los Angeles, had a neurology/neurosurgery
fellowship at the National Hospital for Nervous diseases in London,
a spine fellowship at the University of South Florida / Tampa
General Hospital and a spinal surgery fellowship at the University
of Tennessee. The appointment of Dr. Johnson increases Alphatec's
Scientific Advisory Board to seven members and places him among the
esteemed company of existing SAB members including Stephen H.
Hochschuler, M.D.; Bret B. Abshire, M.D.; Frank Eismont, M.D.;
Steven Garfin, M.D.; Frank Phillips, M.D.; and James J. Yue, M.D.
About Alphatec Alphatec is a medical device company focused on the
design, development, manufacturing and marketing of products for
the surgical treatment of spine disorders. Alphatec's product
offerings are primarily focused on the U.S. spine market, which is
estimated to approach $3 billion in 2007, through its wholly-owned
subsidiary, Alphatec Spine, Inc., and include a variety of spinal
implant products and systems comprised of components such as spine
screws, spinal spacers, and plates that offer multiple solutions to
address patients' needs. In addition to Alphatec's U.S. presence,
it also participates in the Japanese spine fusion and orthopedic
trauma markets through its subsidiary, Alphatec Pacific, Inc.
Alphatec's mission is to be a value-based leader in the spinal
device market by providing unmatched service to and taking
scientific direction from its surgeon customers. Alphatec does so
through its unique in-house manufacturing facility in Carlsbad,
California, that allows us to respond quickly to surgeon needs and
to customize innovative products needed for spine fusion surgery.
Additional information is available at
http://www.alphatecspine.com/. Forward Looking Statements This
press release may contain forward-looking statements that involve
risks and uncertainty. Such statements are based on management's
current expectations and are subject to a number of risks and
uncertainties that could cause actual results to differ materially
from those described in the forward- looking statements. Alphatec
cautions investors that there can be no assurance that actual
results or business conditions will not differ materially from
those projected or suggested in such forward-looking statements as
a result of various factors, including, but not limited to, the
following: Alphatec's ability to maintain its level of previously
reported sales growth, Alphatec's ability to manage, develop and
expand its spine fusion business in the United States and Japan,
Alphatec's ability to expand and maintain a successful sales and
marketing organization, continuation of favorable third party payor
reimbursement for procedures performed using our products,
unanticipated expenses or liabilities or other adverse events
affecting cash flow or Alphatec's ability to achieve profitability,
uncertainty of additional funding, uncertainty of success in
developing any new products or acquiring or licensing leading
technologies in the spine industry on terms acceptable to the
company, failure to successfully introduce and develop new
products, including products related to license agreements, failure
to obtain FDA clearance or approval for particular devices,
Alphatec's ability to compete with other competing products and
with emerging new technologies within and outside of spinal fusion,
product liability exposure, patent infringement claims and claims
related to our intellectual property. Please refer to the risks
detailed in Alphatec's quarterly report on Form 10-Q for the
quarter ended September 30, 2006. We disclaim any intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events, or
otherwise, unless required by law. Contact: Alphatec Spine, Inc.
Steven Yasbek Chief Financial Officer (760) 431-9286 Noonan Russo
Matthew Haines (212) 845-4235 DATASOURCE: Alphatec Holdings, Inc.
CONTACT: Alphatec Spine, Inc., Steven Yasbek, Chief Financial
Officer, +1-760-431-9286, ; Noonan Russo, Matthew Haines,
+1-212-845-4235, , for Alphatec Holdings, Inc. Web site:
http://www.alphatecspine.com/
Copyright
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024